{
    "2021-06-22": [
        [
            {
                "time": "",
                "original_text": "2700亿疫苗巨头大跌，一大传闻突袭？黄金坑来了？",
                "features": {
                    "keywords": [
                        "疫苗",
                        "巨头",
                        "大跌",
                        "传闻",
                        "黄金坑"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块午后转暖，复星医药大涨7%",
                "features": {
                    "keywords": [
                        "疫苗",
                        "板块",
                        "转暖",
                        "复星医药",
                        "大涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深圳康泰生物新冠疫苗在马启动III期临床接种",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "III期",
                        "临床接种"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年半年报业绩前瞻：CXO、生物制品、创新器械、医疗服务有望持续高增长",
                "features": {
                    "keywords": [
                        "医药行业",
                        "半年报",
                        "CXO",
                        "生物制品",
                        "创新器械",
                        "医疗服务",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO",
                        "生物制品",
                        "创新器械",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业简评报告：八部委联合发文推动康复产业加快发展 看好康复产业链“器械+服务”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "康复产业",
                        "八部委",
                        "发文",
                        "器械+服务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "康复产业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：关注国产色谱填料领军企业纳微科技",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "国产色谱填料",
                        "纳微科技"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "色谱填料"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医保法征求意见稿和2021年医改重点工作发布 看好高壁垒创新赛道",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医保法",
                        "医改",
                        "高壁垒",
                        "创新赛道"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医保",
                        "医改"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}